57894-240 : Lazcluze 240 mg Oral Tablet, Film Coated
| NDC: | 57894-240 |
| Labeler: | Janssen Biotech, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: | Lazcluze |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA219008 |
| Rev. Date: |
NDC Package Codes:
- 57894-240-30: 1 BOTTLE IN 1 CARTON (57894‑240‑30) / 30 TABLET, FILM COATED IN 1 BOTTLE
- 57894-240-99: 1 DOSE PACK IN 1 CARTON (57894‑240‑99) / 14 TABLET, FILM COATED IN 1 DOSE PACK
Active Ingredients:
- Lazertinib
Dosage Strength:
- 240 mg
Pharmaceutical Classes:
- Breast Cancer Resistance Protein Inhibitors [MoA]
- Cytochrome P450 3A4 Inhibitors [MoA]
- Kinase Inhibitor [EPC]
- Kinase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 57894-080 Lazcluze 80 mg Oral Tablet, Film Coated by Janssen Biotech, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 57894-225Next: 57894-350 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.